View in EDS

Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.

Saved in:
Bibliographic Details
Title: Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.
Authors: Foss DV; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA., Muldoon JJ; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Nguyen DN; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Carr D; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Sahu SU; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA., Hunsinger JM; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA., Wyman SK; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA., Krishnappa N; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA., Mendonsa R; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA., Schanzer EV; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA., Shy BR; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Vykunta VS; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Allain V; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Université de Paris, INSERM UMR976, Hôpital Saint-Louis, Paris, France., Li Z; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Marson A; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA. alexander.marson@ucsf.edu.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Diabetes Center, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu., Eyquem J; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu., Wilson RC; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu.
Source: Nature biomedical engineering [Nat Biomed Eng] 2023 May; Vol. 7 (5), pp. 647-660. Date of Electronic Publication: 2023 Apr 25.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37147433
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Foss+DV%22">Foss DV</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Muldoon+JJ%22">Muldoon JJ</searchLink>; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+DN%22">Nguyen DN</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Carr+D%22">Carr D</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sahu+SU%22">Sahu SU</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hunsinger+JM%22">Hunsinger JM</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wyman+SK%22">Wyman SK</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Krishnappa+N%22">Krishnappa N</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mendonsa+R%22">Mendonsa R</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schanzer+EV%22">Schanzer EV</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shy+BR%22">Shy BR</searchLink>; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Vykunta+VS%22">Vykunta VS</searchLink>; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Allain+V%22">Allain V</searchLink>; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Université de Paris, INSERM UMR976, Hôpital Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Marson+A%22">Marson A</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA. alexander.marson@ucsf.edu.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Diabetes Center, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Eyquem+J%22">Eyquem J</searchLink>; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Wilson+RC%22">Wilson RC</searchLink>; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101696896%22">Nature biomedical engineering</searchLink> [Nat Biomed Eng] 2023 May; Vol. 7 (5), pp. 647-660. <i>Date of Electronic Publication: </i>2023 Apr 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101696896 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2157-846X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222157846X%22">2157846X </searchLink><i>NLM ISO Abbreviation: </i>Nat Biomed Eng <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37147433
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41551-023-01032-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 647
    Titles:
      – TitleFull: Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Foss DV
      – PersonEntity:
          Name:
            NameFull: Muldoon JJ
      – PersonEntity:
          Name:
            NameFull: Nguyen DN
      – PersonEntity:
          Name:
            NameFull: Carr D
      – PersonEntity:
          Name:
            NameFull: Sahu SU
      – PersonEntity:
          Name:
            NameFull: Hunsinger JM
      – PersonEntity:
          Name:
            NameFull: Wyman SK
      – PersonEntity:
          Name:
            NameFull: Krishnappa N
      – PersonEntity:
          Name:
            NameFull: Mendonsa R
      – PersonEntity:
          Name:
            NameFull: Schanzer EV
      – PersonEntity:
          Name:
            NameFull: Shy BR
      – PersonEntity:
          Name:
            NameFull: Vykunta VS
      – PersonEntity:
          Name:
            NameFull: Allain V
      – PersonEntity:
          Name:
            NameFull: Li Z
      – PersonEntity:
          Name:
            NameFull: Marson A
      – PersonEntity:
          Name:
            NameFull: Eyquem J
      – PersonEntity:
          Name:
            NameFull: Wilson RC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2023 May
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2157-846X
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Nature biomedical engineering
              Type: main
ResultId 1